Trade Summary

5 days ago, Heidbreder Christian, serving as Chief Scientific Officer at Indivior Pharmaceuticals, Inc. (INDV), sold 18,586 shares at $38.06 per share, for a total transaction value of $707,383.16. Following this transaction, Heidbreder Christian now holds 227,923 shares of INDV.

This sale represents a 7.54% decrease in Heidbreder Christian's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 11, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 12, 2026 at 4:10 PM ET, 1 day after the trade was made.

Indivior Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.